Bringing influenza vaccines into the 21st century

References

• Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12:15 - 22; PMID: 16494711
   PubMed Web of Science ®Google Scholar
• Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Field's Virology. Philadeplphia: Lippincott, Williams and Wilkins; pages 1691–740.
   Google Scholar
• Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435 - 6; http://dx.doi.org/10.1038/440435a; PMID: 16554799
   PubMed Web of Science ®Google Scholar
• Schild GC, Oxford JS, de Jong JC, Webster RG. Evidence for host-cell selection of influenza virus antigenic variants. Nature 1983; 303:706 - 9; http://dx.doi.org/10.1038/303706a0; PMID: 6190093
   PubMed Web of Science ®Google Scholar
• Robertson JS, Naeve CW, Webster RG, Bootman JS, Newman R, Schild GC. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 1985; 143:166 - 74; http://dx.doi.org/10.1016/0042-6822(85)90105-9; PMID: 4060580
   PubMed Web of Science ®Google Scholar
• Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, et al. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol 2012; 19:897 - 908; http://dx.doi.org/10.1128/CVI.05726-11; PMID: 22492743
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter A-L, Mahmud SM, Sabaiduc S, Gubbay JB, Charest H, Petric M, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada’s sentinel surveillance network, January 2013. Euro Surveill 2013; 18:18; PMID: 23399422
   PubMedGoogle Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season [Internet]. 2013. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201302_recommendation.pdf
   Google Scholar
• Dormitzer PR. Cell culture-derived influenza vaccines. In: Del Giudice G, Rappuoli R, editors. Influenza vaccines for the future. Basel: Birkhauser Inc; 2010. pages 293–312.
   Google Scholar
• Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, et al. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med 2013; 5:85ra68; http://dx.doi.org/10.1126/scitranslmed.3006368; PMID: 23677594
   PubMed Web of Science ®Google Scholar
• Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, Fabry L, Heldens JGM, Kino Y, Kistner O, et al. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine 2009; 27:2907 - 13; http://dx.doi.org/10.1016/j.vaccine.2009.02.064; PMID: 19366582
   PubMed Web of Science ®Google Scholar
• Katz JM, Wang M, Webster RG. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol 1990; 64:1808 - 11; PMID: 2319652
   PubMed Web of Science ®Google Scholar
• Ito T, Suzuki Y, Takada A, Kawamoto A, Otsuki K, Masuda H, Yamada M, Suzuki T, Kida H, Kawaoka Y. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol 1997; 71:3357 - 62; PMID: 9060710
   PubMed Web of Science ®Google Scholar
• Ramanunninair M, Le J, Onodera S, Fulvini AA, Pokorny BA, Silverman J, Devis R, Arroyo JM, He Y, Boyne A, et al. Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds. PLoS One 2013; 8:e65955; http://dx.doi.org/10.1371/journal.pone.0065955; PMID: 23776579
   PubMed Web of Science ®Google Scholar
• Rappuoli R, Dormitzer PR. Influenza: options to improve pandemic preparation. Science 2012; 336:1531 - 3; http://dx.doi.org/10.1126/science.1221466; PMID: 22723412
   PubMed Web of Science ®Google Scholar
• Schild GC, Wood JM, Newman RW. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ 1975; 52:223 - 31; PMID: 816480
   PubMed Web of Science ®Google Scholar
• Kapteyn JC, Porre AM, de Rond EJP, Hessels WB, Tijms MA, Kessen H, Slotboom AME, Oerlemans MA, Smit D, van der Linden J, et al. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine 2009; 27:1468 - 77; http://dx.doi.org/10.1016/j.vaccine.2008.11.113; PMID: 19110022
   PubMed Web of Science ®Google Scholar
• Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays. Vaccine 2011; 29:3377 - 89; http://dx.doi.org/10.1016/j.vaccine.2011.02.090; PMID: 21397719
   PubMed Web of Science ®Google Scholar
• Williams TL, Luna L, Guo Z, Cox NJ, Pirkle JL, Donis RO, Barr JR. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 2008; 26:2510 - 20; http://dx.doi.org/10.1016/j.vaccine.2008.03.014; PMID: 18440105
   PubMed Web of Science ®Google Scholar
• Harvey R, Hamill M, Robertson JS, Minor PD, Vodeiko GM, Weir JP, Takahashi H, Harada Y, Itamura S, Bamford P, et al. Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards. Biologicals 2012; 40:96 - 9; http://dx.doi.org/10.1016/j.biologicals.2011.12.009; PMID: 22244521
   PubMed Web of Science ®Google Scholar
• Hashem AM, Gravel C, Farnsworth A, Zou W, Lemieux M, Xu K, Li C, Wang J, Goneau M-F, Merziotis M, et al. A novel synthetic receptor-based immunoassay for influenza vaccine quantification. PLoS One 2013; 8:e55428; http://dx.doi.org/10.1371/journal.pone.0055428; PMID: 23424631
   PubMedGoogle Scholar
• Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Influenza Other Respir Viruses 2013; 7:191 - 200; http://dx.doi.org/10.1111/j.1750-2659.2012.00375.x; PMID: 22583601
   PubMed Web of Science ®Google Scholar
• Nilsson CE, Abbas S, Bennemo M, Larsson A, Hämäläinen MD, Frostell-Karlsson A. A novel assay for influenza virus quantification using surface plasmon resonance. Vaccine 2010; 28:759 - 66; http://dx.doi.org/10.1016/j.vaccine.2009.10.070; PMID: 19857452
   PubMed Web of Science ®Google Scholar
• Mount A, Koernig S, Silva A, Drane D, Maraskovsky E, Morelli AB. Combination of adjuvants: the future of vaccine design. Expert Rev Vaccines 2013; 12:733 - 46; http://dx.doi.org/10.1586/14760584.2013.811185; PMID: 23885819
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Rappuoli R, De Gregorio E, Tsai T, Del Giudice G. MF59 adjuvant: the best insurance against influenza strain diversity. Expert Rev Vaccines 2011; 10:447 - 62; http://dx.doi.org/10.1586/erv.11.23; PMID: 21506643
   PubMed Web of Science ®Google Scholar
• Vesikari T, Knuf M, Wutzler P, Karvonen A, Kieninger-Baum D, Schmitt H-J, Baehner F, Borkowski A, Tsai TF, Clemens R. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365:1406 - 16; http://dx.doi.org/10.1056/NEJMoa1010331; PMID: 21995388
   PubMed Web of Science ®Google Scholar
• Hekele A, Bertholet S, Archer J, Gibson DG, Palladino G, Brito LA, Otten GR, Brazzoli M, Buccato S, Bonci A, et al. Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice. Emerg Microbes Infect 2013; 2:e52; http://dx.doi.org/10.1038/emi.2013.54
   PubMed Web of Science ®Google Scholar
• Gilbert SC. Advances in the development of universal influenza vaccines. Influenza Other Respir Viruses 2013; 7:750 - 8; http://dx.doi.org/10.1111/irv.12013; PMID: 22998622
   PubMed Web of Science ®Google Scholar
• Ekiert DC, Bhabha G, Elsliger M-A, Friesen RHE, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. Antibody recognition of a highly conserved influenza virus epitope. Science 2009; 324:246 - 51; http://dx.doi.org/10.1126/science.1171491; PMID: 19251591
   PubMed Web of Science ®Google Scholar
• Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, García-Sastre A, Palese P. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 2010; 1:1; http://dx.doi.org/10.1128/mBio.00018-10; PMID: 20689752
   PubMed Web of Science ®Google Scholar
• Wrammert J, Koutsonanos D, Li G-M, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011; 208:181 - 93; http://dx.doi.org/10.1084/jem.20101352; PMID: 21220454
   PubMed Web of Science ®Google Scholar
• Settembre EC, Dormitzer PR, Rappuoli R. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines. J Mol Cell Biol 2011; 3:144 - 6; http://dx.doi.org/10.1093/jmcb/mjq046; PMID: 21430014
   PubMed Web of Science ®Google Scholar
• Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol 2013; 87:6542 - 50; http://dx.doi.org/10.1128/JVI.00641-13; PMID: 23576508
   PubMed Web of Science ®Google Scholar
• Khurana S, Loving CL, Manischewitz J, King LR, Gauger PC, Henningson J, Vincent AL, Golding H. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci Transl Med 2013; 5:ra114; http://dx.doi.org/10.1126/scitranslmed.3006366; PMID: 23986398
   PubMed Web of Science ®Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2010-2011 northern hemisphere influenza season [Internet]. 2010. Available from: http://www.who.int/influenza/vaccines/virus/recommended_compositionFeb08FullReport.pdf
   Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2008-2009 northern hemisphere influenza season [Internet]. 2008. Available from: http://www.who.int/influenza/vaccines/ recommended_compositionFeb08FullReport.pdf.
   Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2004-2005 northern hemisphere influenza season [Internet]. 2004. Available from: http://www.who.int/influenza/vaccines/virus/recommended_compositionFeb04FullReport.pdf
   Google Scholar